Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Heron Therapeutics, Inc. - Common Stock (NQ:HRTX)

0.3706 UNCHANGED
Delayed Quote Updated: 4:00 PM EST, Nov 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Heron Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Most Active Stocks: November 9, 2026 Session ↗
Via Chartmill
Top Movers Today: MF Gains 89.56%, ZURA Falls 72.98% ↗
Via Chartmill
US Gap-Up and Gap-Down Movers for the Nov. 9, 2026 Session ↗
Via Chartmill
Heron Therapeutics (NASDAQ:HRTX) Q3 Revenue Misses Estimates as CorMedix Asset Deal Lifts Shares ↗
Via Chartmill
Premarket Movers on Nov. 9, 2026: Small-Cap Gainers and Losers ↗
Via Chartmill
Heron Therapeutics Q1 Results Miss, but Acute Care Growth and Reaffirmed Outlook Support HRTX ↗
Via Chartmill
Heron Therapeutics Inc (NASDAQ:HRTX) Reports Q4 2025 Revenue Beat and Positive 2026 Outlook ↗
Via Chartmill
News headline image
Heron Therapeutics Announces Third Quarter 2026 Financial Results
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron Therapeutics to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
From Heron Therapeutics, Inc.
Via GlobeNewswire
These stocks are moving in today's after hours session ↗
Via Chartmill
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
Via Chartmill
News headline image
Heron (HRTX) Q2 2026 Earnings Call Transcript ↗
Patent setback forces guidance withdrawal as acute care revenue surges 44% year over year. 
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
Heron Therapeutics Q2 Earnings Call Highlights ↗
Heron Therapeutics (NASDAQ:HRTX) reported second-quarter net revenue of $37.7 million, up from $34.7 million in the first quarter and $37.2 million in the comparable prior-year period, while management... 
Via MarketBeat
Topics Earnings Intellectual Property
News headline image
Heron Therapeutics Announces Second Quarter 2026 Financial Results
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026
From Heron Therapeutics, Inc.
Via GlobeNewswire
Keep an eye on the top gainers and losers in Tuesday's session. ↗
Via Chartmill
These stocks are moving in today's session ↗
Via Chartmill
Tuesday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
U.S. District Court Issues Decision Regarding CINVANTI® Patents
After Reviewing the Ruling, Heron Believes It has Substantial Grounds for Obtaining Reversal in an Appeal 
From Heron Therapeutics, Inc.
Via GlobeNewswire
Which stocks are moving after the closing bell on Monday? ↗
Via Chartmill
News headline image
Heron (HRTX) Q1 2026 Earnings Call Transcript ↗
Heron (HRTX) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Supply Chain
Which stocks are moving on Monday? ↗
Via Chartmill
News headline image
Heron Therapeutics Q1 Earnings Call Highlights ↗
Heron Therapeutics (NASDAQ:HRTX) said first-quarter 2026 results were pressured by seasonal factors and severe winter weather, but management reaffirmed its full-year outlook and pointed to improving... 
Via MarketBeat
Topics Earnings
The market is filled with gapping stocks in Monday's session. ↗
Via Chartmill
News headline image
Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron (HRTX) Q4 2025 Earnings Call Transcript ↗
Heron (HRTX) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026
From Heron Therapeutics, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.